Advertisement
Monday, Nov 29, 2021
Outlook.com
Outlook.com

10,000 Doses Of DRDO’s Antiviral Covid Drug To Be Distributed On Monday: Reports

DRDO’s 2-deoxy-D-glucose (2-DG) drug can cure moderate to severe Covid-19 infections, officials said.

10,000 Doses Of DRDO’s Antiviral Covid Drug To Be Distributed On Monday: Reports
Clinical trials of DRDO’s drug-- 2-deoxy-D-glucose (2-DG) showed that it helps in faster recovery of hospitalised Covid patients | Representational Image/ Unsplash
10,000 Doses Of DRDO’s Antiviral Covid Drug To Be Distributed On Monday: Reports
outlookindia.com
2021-05-16T22:37:47+05:30

An antiviral Covid-19 drug developed by the Defence Research and Development Organisation (DRDO) will be made available for emergency use starting tomorrow, reports claimed.

According to NDTV, Defence minister Rajnath Singh will distribute 10,000 doses of the drug to various hospitals in Delhi.

The drug was approved by the Drugs Controller General of India (DCGI), earlier this week. It is an oral drug and can cure moderate to severe Covid-19 infections, officials said.

These developments come at a time when many states and Union Territories are facing a shortage of key medicines used for the treatment of Covid-19.

Clinical trials of DRDO’s drug-- 2-deoxy-D-glucose (2-DG) showed that it helps in faster recovery of hospitalised Covid patients and reduces supplemental oxygen dependence, DCGI had said earlier.

"In the ongoing second Covid-19 wave, a large number of patients are facing severe oxygen dependency and need hospitalisation.

"The drug is expected to save precious lives due to the mechanism of operation of the drug in infected cells. This also reduces the hospital stay of Covid-19 patients," the defence ministry had said.

The ministry had further said that the anti-Covid-19 therapeutic application of 2-DG drug has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a leading laboratory of Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddy's Laboratories (DRL) in Hyderabad.

Advertisement

Outlook Newsletters

Advertisement
Advertisement
Advertisement

Read More from Outlook

Heavy Fines, Media Gag: Maharashtra Learns From Past As It Gears To Tackle Omicron

Heavy Fines, Media Gag: Maharashtra Learns From Past As It Gears To Tackle Omicron

Maharashtra CM Uddhav Thackeray has instructed all the ministers in charge of the districts to tighten coordination with the local administration to ensure proper prevention of another Covid-19 outbreak.

Omicron Shows Why Countries Need To Start Sharing Their Vaccines

Omicron Shows Why Countries Need To Start Sharing Their Vaccines

'Despite the repeated warnings of health leaders, our failure to put vaccines into the arms of people in the developing world is now coming back to haunt us', wrote former British PM Gordon Brown.

Iyer Plays Down Record, Says 'Important Thing Is To Win Match'

Iyer Plays Down Record, Says 'Important Thing Is To Win Match'

Shreyas Iyer hit 105 and 65 against New Zealand to become the first Indian batter to score a century and half-century in his debut Test match.

Covid-19: Experts' Take On Omicron And Possibility Of Third Wave In India

Covid-19: Experts' Take On Omicron And Possibility Of Third Wave In India

Though the health experts and scientists in India have advised caution yet they feel that the current immune profile of the majority of the population in India makes them less vulnerable to Omicron as compared to any other country in the world.

Advertisement